Remus Pharmaceuticals Ltd. makes a strong debut on the bourses with scrip got listed at Rs 1,711.25 on the Bombay Stock Exchange, a 39.23 per cent premium to its issue price of Rs 1,229.00. On the National Stock Exchange, the stock was listed at Rs 1,711.25.

The company, which raised 0.04 Cr from initial public offering, was subscribed 61.63 times, receiving bids for 239.12 lakhs shares against the total issue size of 3.88 lakhs shares.

The company, listed under ST Group Securities post its IPO, opened for subscription from May 17 to May 19.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the NSE.

The company anticipates using the proceeds of the issue for .

Beeline Capital Advisors Pvt. Ltd. as lead managers & Link Intime India Private Limited is the registrar, to the issue.

Meanwhile, the broader benchmark NSE Nifty closed trade at 18,499.35, up 178.20 points, or 0.97 per cent.